RIPK1 and neurodegenerative disease: Our study suggests that inhibition of RIPK1 may reduce neuroinflammation and the accumulation of misfolded proteins in neurodegenerative diseases that are not genetically connected with mutations in the genes that directly regulate the activation of RIPK1.